Disc Medicine (IRON) Long-Term Debt Issuances (2020)

Disc Medicine's (IRON) quarterly Long-Term Debt Issuances came in at $200000.0 in Q4 2020, little changed on a QoQ basis from $200000.0 in Q3 2020.

Disc Medicine (IRON) Long-Term Debt Issuances (2020) Analysis & Trends

Disc Medicine (IRON) has 1 years of Long-Term Debt Issuances data on file, last reported at $200000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Disc Medicine 2.90 Bn 2.90 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 200,000.00
Dec 31, 2020 200,000.00
Sep 30, 2020 200,000.00
Sep 30, 2020 200,000.00